The prognostic value of preoperative controlling nutritional status score in non-metastatic renal cell carcinoma treated with surgery: a retrospective single-institution study

References

• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.2149230207593
   PubMed Web of Science ®Google Scholar
• Kyoda Y, Kobayashi K, Hirobe M, et al. Evaluation of long-term outcome for patients with renal cell carcinoma after surgery: analysis of cancer deaths occurring more than 10 years after initial treatment. Int J Clin Oncol. 2014;19(1):146–151. doi:10.1007/s10147-013-0533-x23404486
   PubMed Web of Science ®Google Scholar
• Gong J, Maia MC, Dizman N, Govindarajan A, Pal SK. Metastasis in renal cell carcinoma: biology and implications for therapy. Asian J Urol. 2016;3(4):286–292. doi:10.1016/j.ajur.2016.08.00629264197
   PubMed Web of Science ®Google Scholar
• Hu H, Yao X, Xie X, et al. Prognostic value of preoperative NLR, dNLR, PLR and CRP in surgical renal cell carcinoma patients. World J Urol. 2017;35(2):261–270. doi:10.1007/s00345-016-1864-927255479
   PubMed Web of Science ®Google Scholar
• Semeniuk-Wojtas A, Lubas A, Stec R, Syrylo T, Niemczyk S, Szczylik C. Neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and c-reactive protein as new and simple prognostic factors in patients with metastatic renal cell cancer treated with tyrosine kinase inhibitors: a systemic review and meta-analysis. Clin Genitourin Cancer. 2018;16(3):e685–e693. doi:10.1016/j.clgc.2018.01.01029454639
   PubMed Web of Science ®Google Scholar
• Wang Z, Peng S, Wang A, et al. Platelet-lymphocyte ratio acts as an independent predictor of prognosis in patients with renal cell carcinoma. Clin Chim Acta. 2018;480:166–172. doi:10.1016/j.cca.2018.02.01429462592
   PubMed Web of Science ®Google Scholar
• Byun SS, Hwang EC, Kang SH, et al. Age-dependent prognostic value of body mass index for non-metastatic clear cell renal cell carcinoma: a large multicenter retrospective analysis. J Surg Oncol. 2018;118(1):199–205. doi:10.1002/jso.2510429949668
   PubMed Web of Science ®Google Scholar
• Jeon HG, Choi DK, Sung HH, et al. Preoperative prognostic nutritional index is a significant predictor of survival in renal cell carcinoma patients undergoing nephrectomy. Ann Surg Oncol. 2016;23(1):321–327. doi:10.1245/s10434-015-4614-026045392
   PubMed Web of Science ®Google Scholar
• Hofbauer SL, Pantuck AJ, de Martino M, et al. The preoperative prognostic nutritional index is an independent predictor of survival in patients with renal cell carcinoma. Urol Oncol. 2015;33(2):68.e61-67. doi:10.1016/j.urolonc.2014.08.005
   PubMed Web of Science ®Google Scholar
• Fukushima H, Nakanishi Y, Kataoka M, Tobisu K, Koga F. Prognostic significance of sarcopenia in patients with metastatic renal cell carcinoma. J Urol. 2016;195(1):26–32. doi:10.1016/j.juro.2015.08.07126292042
   PubMed Web of Science ®Google Scholar
• Tsujino T, Komura K, Matsunaga T, et al. Preoperative measurement of the modified glasgow prognostic score predicts patient survival in non-metastatic renal cell carcinoma prior to nephrectomy. Ann Surg Oncol. 2017;24(9):2787–2793. doi:10.1245/s10434-017-5948-628643013
   PubMed Web of Science ®Google Scholar
• Ignacio de Ulibarri J, Gonzalez-Madrono A, de Villar NG, et al. CONUT: a tool for controlling nutritional status. First validation in a hospital population. Nutr Hosp. 2005;20(1):38–45.
   PubMedGoogle Scholar
• Yoshida N, Baba Y, Shigaki H, et al. Preoperative nutritional assessment by Controlling Nutritional Status (CONUT) is useful to estimate postoperative morbidity after esophagectomy for esophageal cancer. World J Surg. 2016;40(8):1910–1917. doi:10.1007/s00268-016-3549-327220507
   PubMed Web of Science ®Google Scholar
• Kuroda D, Sawayama H, Kurashige J, et al. Controlling Nutritional Status (CONUT) score is a prognostic marker for gastric cancer patients after curative resection. Gastric Cancer. 2018;21(2):204–212. doi:10.1007/s10120-017-0744-328656485
   PubMed Web of Science ®Google Scholar
• Iseki Y, Shibutani M, Maeda K, et al. Impact of the preoperative Controlling Nutritional Status (CONUT) score on the survival after curative surgery for colorectal cancer. PLoS One. 2015;10(7):e0132488. doi:10.1371/journal.pone.013248826147805
   PubMed Web of Science ®Google Scholar
• Ishihara H, Kondo T, Yoshida K, et al. Preoperative controlling nutritional status (CONUT) score as a novel predictive biomarker of survival in patients with localized urothelial carcinoma of the upper urinary tract treated with radical nephroureterectomy. Urol Oncol. 2017;35(9):539.e539-539.e516. doi:10.1016/j.urolonc.2017.04.012
   Web of Science ®Google Scholar
• Karam JA, Lotan Y, Karakiewicz PI, et al. Use of combined apoptosis biomarkers for prediction of bladder cancer recurrence and mortality after radical cystectomy. Lancet Oncol. 2007;8(2):128–136. doi:10.1016/S1470-2045(07)70002-517267327
   PubMed Web of Science ®Google Scholar
• Harimoto N, Yoshizumi T, Sakata K, et al. Prognostic significance of Preoperative Controlling Nutritional Status (CONUT) score in patients undergoing hepatic resection for hepatocellular carcinoma. World J Surg. 2017;41(11):2805–2812. doi:10.1007/s00268-017-4097-128653142
   PubMed Web of Science ®Google Scholar
• Deehan DJ, Heys SD, Simpson W, Herriot R, Broom J, Eremin O. Correlation of serum cytokine and acute phase reactant levels with alterations in weight and serum albumin in patients receiving immunotherapy with recombinant IL-2. Clin Exp Immunol. 1994;95(3):366–372. doi:10.1111/j.1365-2249.1994.tb07005.x7511074
   PubMed Web of Science ®Google Scholar
• Heys SD, Walker LG, Deehan DJ, Eremin OE. Serum albumin: a prognostic indicator in patients with colorectal cancer. J R Coll Surg Edinb. 1998;43(3):163–168.9654876
   PubMedGoogle Scholar
• Tanriverdi O. A discussion of serum albumin level in advanced-stage hepatocellular carcinoma: a medical oncologist’s perspective. Med Oncol. 2014;31(11):282. doi:10.1007/s12032-014-0374-025316265
   PubMed Web of Science ®Google Scholar
• Gupta D, Lis CGJNJ. Pretreatment serum albumin as a predictor of cancer survival: a systematic review of the epidemiological literature. Nutr J. 2010;9(1):69.21176210
   PubMedGoogle Scholar
• Ishizuka M, Nagata H, Takagi K, Kubota K. Influence of inflammation-based prognostic score on mortality of patients undergoing chemotherapy for far advanced or recurrent unresectable colorectal cancer. Ann Surg. 2009;250(2):268–272. doi:10.1097/SLA.0b013e3181b16e2419638907
   PubMed Web of Science ®Google Scholar
• Kark JD, Smith AH, Hames CG. Serum retinol and the inverse relationship between serum cholesterol and cancer. Br Med J. 1982;284(6310):152–154. doi:10.1136/bmj.284.6310.1526799076
   PubMedGoogle Scholar
• Kitahara CM, Berrington de Gonzalez A, Freedman ND, et al. Total cholesterol and cancer risk in a large prospective study in Korea. J Clin Oncol. 2011;29(12):1592–1598. doi:10.1200/JCO.2010.31.520021422422
   PubMed Web of Science ®Google Scholar
• Williams RR, Sorlie PD, Feinleib M, McNamara PM, Kannel WB, Dawber TR. Cancer incidence by levels of cholesterol. JAMA. 1981;245(3):247–252.7452849
   PubMed Web of Science ®Google Scholar
• Wu B, Teng L, He D, Yu -D-D, Jiang F. Dose-response relation between serum total cholesterol levels and overall cancer risk: evidence from 12 prospective studies involving 1,926,275 participants. Int J Food Sci Nutr. 2018;70:1–10.29671359
   PubMed Web of Science ®Google Scholar
• Niendorf A, Nägele H, Gerding D, Meyer-Pannwitt U, Gebhardt A. Increased LDL receptor mRNA expression in colon cancer is correlated with a rise in plasma cholesterol levels after curative surgery. Int J Cancer. 1995;61(4):461–464. doi:10.1002/ijc.29106104057759150
   PubMed Web of Science ®Google Scholar
• Cengiz O, Kocer B, Surmeli S, Santicky MJ, Soran A. Are pretreatment serum albumin and cholesterol levels prognostic tools in patients with colorectal carcinoma? Med Sci Monit. 2006;12(6):CR240–247.16733481
   PubMed Web of Science ®Google Scholar
• Roxburgh CS, McMillan DC. Role of systemic inflammatory response in predicting survival in patients with primary operable cancer. Future Oncol. 2010;6(1):149–163. doi:10.2217/fon.09.13620021215
   PubMed Web of Science ®Google Scholar
• Hadrup S, Donia M, Thor Straten P. Effector CD4 and CD8 T cells and their role in the tumor microenvironment. Cancer Microenviron. 2013;6(2):123–133. doi:10.1007/s12307-012-0127-623242673
   PubMedGoogle Scholar
• Badalamenti G, Fanale D, Incorvaia L, et al. Role of tumor-infiltrating lymphocytes in patients with solid tumors: can a drop dig a stone? Cell Immunol. 2018. doi:10.1016/j.cellimm.2018.01.013
   PubMed Web of Science ®Google Scholar
• Feng JF, Liu JS, Huang Y. Lymphopenia predicts poor prognosis in patients with esophageal squamous cell carcinoma. Medicine (Baltimore). 2014;93(27):e257. doi:10.1097/MD.000000000000025725501097
   PubMed Web of Science ®Google Scholar
• Saroha S, Uzzo RG, Plimack ER, Ruth K, Al-Saleem T. Lymphopenia is an independent predictor of inferior outcome in clear cell renal carcinoma. J Urol. 2013;189(2):454–460. doi:10.1016/j.juro.2012.09.16623041457
   PubMed Web of Science ®Google Scholar
• Templeton AJ, McNamara MG, Seruga B, et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. Jnci-J Natl Cancer I. 2014;106(6): dju124.
   Web of Science ®Google Scholar
• Zhou X, Du YP, Huang ZB, et al. Prognostic value of PLR in various cancers: a meta-analysis. PLoS One. 2014;9(6): e101119.
   Web of Science ®Google Scholar
• Strohlein MA, Lefering R, Bulian DR, Heiss MM. Relative lymphocyte count is a prognostic parameter in cancer patients with catumaxomab immunotherapy. Med Hypotheses. 2014;82(3):295–299. doi:10.1016/j.mehy.2013.12.01424411128
   PubMed Web of Science ®Google Scholar